长鸿高科(605008) - 2025 Q2 - 季度业绩预告

Half-Year Performance Forecast The company projects a significant decline in its 2025 first-half performance, with net profit attributable to shareholders decreasing sharply and non-recurring net profit turning to a loss - The performance forecast period is from January 1, 2025, to June 30, 2025[3] 2025 Half-Year Performance Forecast | Indicator | Estimated Amount (RMB in millions) | Compared to Prior Year Period (RMB in millions) | Year-over-Year Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 4.00 to 6.00 | Decrease by 90.57 to 92.57 | -93.79% to -95.86% | | Net Profit After Non-Recurring Gains/Losses | -3.00 to -1.50 | Decrease by 72.16 to 73.66 | -102.12% to -104.25% | Prior Year Period Performance In the prior year period (2024), the company achieved profitability, with net profit attributable to shareholders at RMB 96.57 million and net profit after non-recurring gains and losses at RMB 70.66 million 2024 Half-Year Performance Review | Indicator | Amount (RMB in millions) | | :--- | :--- | | Total Profit | 105.59 | | Net Profit Attributable to Shareholders | 96.57 | | Net Profit After Non-Recurring Gains/Losses | 70.66 | | Basic Earnings Per Share (RMB) | 0.15 | Main Reasons for Performance Decline Forecast The performance decline is primarily due to prolonged production halts from a subsidiary's PBT equipment upgrade and reduced gross margins caused by product price drops exceeding raw material cost reductions amid insufficient market demand; however, the company notes stabilized production and market recovery in Q2, leading to improved profitability - Subsidiary Zhejiang Changhong Biomaterials Co., Ltd. underwent a PBT equipment upgrade in Q1 2025, with prolonged downtime impacting production volume[8] - Gross margin declined due to product selling price reductions exceeding raw material cost decreases, driven by temporary insufficient market demand[8] - Production gradually stabilized and market trends showed recovery from Q2 onwards, leading to improved overall company profitability in the second quarter[8] Risk Warning The company explicitly states that this performance forecast is based on preliminary, unaudited data from its finance department, with no material uncertainties believed to affect its accuracy - This performance forecast has not been audited by a certified public accountant[9] - The data is based on the professional judgment of the company's finance department, with no material uncertainties believed to affect the forecast's accuracy[9] Other Explanations The company advises investors that the disclosed data is preliminary, with final accurate financial figures to be officially released in the 2025 half-year report, urging caution regarding investment risks - The forecast data is preliminary, and the final accurate figures will be subject to the company's officially disclosed 2025 half-year report[10] - Investors are advised to be aware of investment risks[10]